American pharma giants are increasingly turning to Chinese labs to discover, test and develop cutting-edge drugs.

On today’s Big Take Asia podcast, Bloomberg’s Amber Tong and Robert Langreth join Oanh Ha to break down why global drugmakers are sourcing their next big breakthroughs from China — and what that means for US biotech dominance.